According to Toshiba's release, the company noted that, "if Toshiba recognizes gains from the sale within FY2015, as a result of the transaction in which Toshiba has determinately transferred all of its shares of TMSC [Toshiba America Medical Systems], the company is expected to record approximately 590.0 billion yen (consolidated, profit (loss) before taxes, approximate). The company is currently working on its accounting treatment in a careful manner."

TMSC will also "be classified as a discontinued operation in Toshiba’s FY2015 consolidated profit and loss statements."


The upshot?

The company stated that it is now "recalculating its financial forecast for FY2015 to reflect the impact of various items, including the transaction."

Just this week, despite a new greater operating loss forecast by Toshiba — due to losses from its Westinghouse nuclear business — its net loss should narrow, from 710 billion yen to 470 billion yen, thanks to a 380 billion profit from the TMSC sale to Canon, according to Nikkei News.

Further reading:

• March 9 statement from Toshiba on granting exclusive negotiating rights to Canon


• March 17 statement from Toshiba on sale of medical unit

Back to HCB News

Business Affairs Homepage